227 related articles for article (PubMed ID: 27397758)
1. Single treatment of VX poisoned guinea pigs with the phosphotriesterase mutant C23AL: Intraosseous versus intravenous injection.
Wille T; Neumaier K; Koller M; Ehinger C; Aggarwal N; Ashani Y; Goldsmith M; Sussman JL; Tawfik DS; Thiermann H; Worek F
Toxicol Lett; 2016 Sep; 258():198-206. PubMed ID: 27397758
[TBL] [Abstract][Full Text] [Related]
2. Post-exposure treatment of VX poisoned guinea pigs with the engineered phosphotriesterase mutant C23: a proof-of-concept study.
Worek F; Seeger T; Reiter G; Goldsmith M; Ashani Y; Leader H; Sussman JL; Aggarwal N; Thiermann H; Tawfik DS
Toxicol Lett; 2014 Nov; 231(1):45-54. PubMed ID: 25195526
[TBL] [Abstract][Full Text] [Related]
3. Post-VX exposure treatment of rats with engineered phosphotriesterases.
Stigler L; Köhler A; Koller M; Job L; Escher B; Potschka H; Thiermann H; Skerra A; Worek F; Wille T
Arch Toxicol; 2022 Feb; 96(2):571-583. PubMed ID: 34962578
[TBL] [Abstract][Full Text] [Related]
4. Catalytic efficiencies of directly evolved phosphotriesterase variants with structurally different organophosphorus compounds in vitro.
Goldsmith M; Eckstein S; Ashani Y; Greisen P; Leader H; Sussman JL; Aggarwal N; Ovchinnikov S; Tawfik DS; Baker D; Thiermann H; Worek F
Arch Toxicol; 2016 Nov; 90(11):2711-2724. PubMed ID: 26612364
[TBL] [Abstract][Full Text] [Related]
5. Bioscavenger is effective as a delayed therapeutic intervention following percutaneous VX poisoning in the guinea-pig.
Mann TM; Price ME; Whitmore CL; Perrott RL; Laws TR; McColm RR; Emery ER; Tattersall JEH; Green AC; Rice H
Toxicol Lett; 2018 Sep; 293():198-206. PubMed ID: 29183815
[TBL] [Abstract][Full Text] [Related]
6. Human plasma-derived BuChE as a stoichiometric bioscavenger for treatment of nerve agent poisoning.
Mumford H; Docx CJ; Price ME; Green AC; Tattersall JE; Armstrong SJ
Chem Biol Interact; 2013 Mar; 203(1):160-6. PubMed ID: 22981459
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of the rePON1 mutant IIG1 to prevent cyclosarin toxicity in vivo and to detoxify structurally different nerve agents in vitro.
Worek F; Seeger T; Goldsmith M; Ashani Y; Leader H; Sussman JS; Tawfik D; Thiermann H; Wille T
Arch Toxicol; 2014 Jun; 88(6):1257-66. PubMed ID: 24477626
[TBL] [Abstract][Full Text] [Related]
8. A catalytic bioscavenger with improved stability and reduced susceptibility to oxidation for treatment of acute poisoning with neurotoxic organophosphorus compounds.
Job L; Köhler A; Escher B; Worek F; Skerra A
Toxicol Lett; 2020 Mar; 321():138-145. PubMed ID: 31891759
[TBL] [Abstract][Full Text] [Related]
9. Toxicokinetics of the nerve agent (+/-)-VX in anesthetized and atropinized hairless guinea pigs and marmosets after intravenous and percutaneous administration.
van der Schans MJ; Lander BJ; van der Wiel H; Langenberg JP; Benschop HP
Toxicol Appl Pharmacol; 2003 Aug; 191(1):48-62. PubMed ID: 12915103
[TBL] [Abstract][Full Text] [Related]
10. Supralethal poisoning by any of the classical nerve agents is effectively counteracted by procyclidine regimens in rats.
Myhrer T; Mariussen E; Enger S; Aas P
Neurotoxicology; 2015 Sep; 50():142-8. PubMed ID: 26318504
[TBL] [Abstract][Full Text] [Related]
11. The evolution of phosphotriesterase for decontamination and detoxification of organophosphorus chemical warfare agents.
Bigley AN; Raushel FM
Chem Biol Interact; 2019 Aug; 308():80-88. PubMed ID: 31100274
[TBL] [Abstract][Full Text] [Related]
12. Catalytic activity and stereoselectivity of engineered phosphotriesterases towards structurally different nerve agents in vitro.
Köhler A; Escher B; Job L; Koller M; Thiermann H; Skerra A; Worek F
Arch Toxicol; 2021 Aug; 95(8):2815-2823. PubMed ID: 34160649
[TBL] [Abstract][Full Text] [Related]
13. A mixture of three engineered phosphotriesterases enables rapid detoxification of the entire spectrum of known threat nerve agents.
Despotović D; Aharon E; Dubovetskyi A; Leader H; Ashani Y; Tawfik DS
Protein Eng Des Sel; 2019 Dec; 32(4):169-174. PubMed ID: 31612205
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and physiological effects of human butyrylcholinesterase as a post-exposure therapy against percutaneous poisoning by VX in the guinea-pig.
Mumford H; Price ME; Cerasoli DM; Teschner W; Ehrlich H; Schwarz HP; Lenz DE
Chem Biol Interact; 2010 Sep; 187(1-3):304-8. PubMed ID: 20176007
[TBL] [Abstract][Full Text] [Related]
15. Rapid and complete bioavailability of antidotes for organophosphorus nerve agent and cyanide poisoning in minipigs after intraosseous administration.
Murray DB; Eddleston M; Thomas S; Jefferson RD; Thompson A; Dunn M; Vidler DS; Clutton RE; Blain PG
Ann Emerg Med; 2012 Oct; 60(4):424-30. PubMed ID: 22738685
[TBL] [Abstract][Full Text] [Related]
16. Overcoming the Challenges of Enzyme Evolution To Adapt Phosphotriesterase for V-Agent Decontamination.
Bigley AN; Desormeaux E; Xiang DF; Bae SY; Harvey SP; Raushel FM
Biochemistry; 2019 Apr; 58(15):2039-2053. PubMed ID: 30893549
[TBL] [Abstract][Full Text] [Related]
17. Phosphotriesterase variants with high methylphosphonatase activity and strong negative trade-off against phosphotriesters.
Briseño-Roa L; Timperley CM; Griffiths AD; Fersht AR
Protein Eng Des Sel; 2011 Jan; 24(1-2):151-9. PubMed ID: 21037279
[TBL] [Abstract][Full Text] [Related]
18. Butyrylcholinesterase as a therapeutic drug for protection against percutaneous VX.
Lenz DE; Clarkson ED; Schulz SM; Cerasoli DM
Chem Biol Interact; 2010 Sep; 187(1-3):249-52. PubMed ID: 20513442
[TBL] [Abstract][Full Text] [Related]
19. SAR study to find optimal cholinesterase reactivator against organophosphorous nerve agents and pesticides.
Gorecki L; Korabecny J; Musilek K; Malinak D; Nepovimova E; Dolezal R; Jun D; Soukup O; Kuca K
Arch Toxicol; 2016 Dec; 90(12):2831-2859. PubMed ID: 27582056
[TBL] [Abstract][Full Text] [Related]
20. Repetitive antidotal treatment is crucial in eliminating eye pathology, respiratory toxicity and death following whole-body VX vapor exposure in freely moving rats.
Bloch-Shilderman E; Yacov G; Cohen L; Egoz I; Gutman H; Gez R; Rabinovitz I; Nili U
Arch Toxicol; 2019 May; 93(5):1365-1384. PubMed ID: 30729277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
